Evaluation of subcutaneous versus mucosal (intranasal) allergen-specific rush immunotherapy in experimental feline asthma (Q83186989)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144412 AND SRC:MED&resulttype=core&format=json

19 January 2020

title

Evaluation of subcutaneous versus mucosal (intranasal) allergen-specific rush immunotherapy in experimental feline asthma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144412 AND SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

1 reference

Tekla M Lee-Fowler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144412 AND SRC:MED&resulttype=core&format=json

19 January 2020

Leah A Cohn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144412 AND SRC:MED&resulttype=core&format=json

19 January 2020

Amy E DeClue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144412 AND SRC:MED&resulttype=core&format=json

19 January 2020

Christine M Spinka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144412 AND SRC:MED&resulttype=core&format=json

19 January 2020

Carol R Reinero

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144412 AND SRC:MED&resulttype=core&format=json

19 January 2020

publication date

9 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144412 AND SRC:MED&resulttype=core&format=json

Veterinary Immunology and Immunopathology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144412 AND SRC:MED&resulttype=core&format=json

19 January 2020

volume

129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144412 AND SRC:MED&resulttype=core&format=json

19 January 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144412 AND SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

49-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144412 AND SRC:MED&resulttype=core&format=json

Comparative analysis of nasal and oral mucosa dendritic cells

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Characterization of dendritic cells from human oral mucosa: a new Langerhans' cell type with high constitutive FcepsilonRI expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Specific immunotherapy in rhinitis and asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Asthma. From bronchoconstriction to airways inflammation and remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Therapeutic manipulation of the immune system: enhancement of innate and adaptive mucosal immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Asthma: mechanisms of disease persistence and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Accelerated immunotherapy schedules: review of efficacy and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Mucosal immunity and tolerance: relevance to vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Basic mechanisms of development of airway structural changes in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

The ACVD task force on canine atopic dermatitis (XXIV): allergen-specific immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Bronchoalveolar lavage in the evaluation of pulmonary disease in the dog and cat. State of the art.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Immunostimulatory DNA is a potent mucosal adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Effect of rush immunotherapy on airway inflammation and airway hyperresponsiveness after bronchoprovocation with allergen in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Systemic reactions and fatalities associated with allergen immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Immune mechanisms of allergen-specific sublingual immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Allergen-specific sublingual immunotherapy for respiratory allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Rush immunotherapy in an experimental model of feline allergic asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Adjuvanted rush immunotherapy using CpG oligodeoxynucleotides in experimental feline allergic asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Intranasal immunotherapy is more effective than intradermal immunotherapy for the induction of airway allergen tolerance in Th2-sensitized mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Mechanisms of immunotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Mucosal tolerance induction with hypoallergenic molecules in a murine model of allergic asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2008.12.008

10.1016/J.VETIMM.2008.12.008

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144412 AND SRC:MED&resulttype=core&format=json

19 January 2020

1 reference